As 2025 wraps up, we’re taking a moment to reflect on an exceptional year - one made possible through the support, collaboration and trust of our customers, partners, suppliers, and industry colleagues.
This year has seen significant progress across our platforms with new customer partnerships, and industry recognition that reflects our continued growth.
Major platform deployments
-
-
- Earlier this month, following a successful Factory Acceptance Test, our first roboFIL™ system left our workshop for Dalton Pharma Services in Canada. This fully automated, high-speed aseptic powder filling platform is now supporting their advanced drug development and manufacturing operations.
- Our cryoFIL® platform was shipped to Cellular Origins, marking a key milestone in our collaboration, integrating cryoFIL® with their Constellation™ robotic manufacturing system. Several additional systems were also shipped to customers in the US this year.
- We also signed off on our first multi-million pound DPI blister filling line sale - more news on this in 2026.
Awards & recognition
2025 has been a standout year for industry recognition:
-
-
- ISPE UK Manufacturing Innovation of the Year Award, shared with Nova Laboratories, recognising a collaborative breakthrough in compact aseptic fill-finish automation.
- Medilink UK National Innovation Award for cryoFIL®, celebrating its impact as a pioneering technology driving efficient, scalable production of advanced therapies.
- Princess Royal Training Awards accreditation for our Graduate Development Programme, recognising our commitment to high-quality training and talent development.
These awards reflect not only technological advancements, but also our values: innovation, collaboration, and excellence in people development.
Reflecting on a year of growth